109 related articles for article (PubMed ID: 28846747)
1. Distinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy.
Gál B; Veselý M; Čolláková J; Nekulová M; Jůzová V; Chmelík R; Veselý P
PLoS One; 2017; 12(8):e0183399. PubMed ID: 28846747
[TBL] [Abstract][Full Text] [Related]
2. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of GLUT1, p63 and phosphorylated histone H1 in head and neck squamous intraepithelial neoplasia: evidence for aberrations in hypoxia-related, cell cycle- and stem-cell-regulatory pathways.
Burstein DE; Nagi C; Kohtz DS; Lumerman H; Wang BY
Histopathology; 2006 May; 48(6):708-16. PubMed ID: 16681687
[TBL] [Abstract][Full Text] [Related]
4. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma.
Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF
J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071
[TBL] [Abstract][Full Text] [Related]
5. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma.
Wu M; Kafanas A; Gan L; Kohtz DS; Zhang L; Genden E; Burstein DE
Diagn Cytopathol; 2008 Nov; 36(11):797-800. PubMed ID: 18831009
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
8. Coherence controlled holographic microscopy - a tool for detection of new biomarkers of head and neck squamous cell carcinoma.
Veselý M; Gál B; Rottenberg J; Palenik M; Hanák J; Zicha D
Klin Onkol; 2022; 35(2):128-131. PubMed ID: 35459337
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma.
Nieh S; Jao SW; Yang CY; Lin YS; Tseng YH; Liu CL; Lee TY; Liu TY; Chu YH; Chen SF
Head Neck; 2015 Dec; 37(12):1712-21. PubMed ID: 24986226
[TBL] [Abstract][Full Text] [Related]
10. Motility-related proteins as markers for head and neck squamous cell cancer.
Abraham MT; Kuriakose MA; Sacks PG; Yee H; Chiriboga L; Bearer EL; Delacure MD
Laryngoscope; 2001 Jul; 111(7):1285-9. PubMed ID: 11568556
[TBL] [Abstract][Full Text] [Related]
11. Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.
Schilling D; Bayer C; Geurts-Moespot A; Sweep FC; Pruschy M; Mengele K; Sprague LD; Molls M
BMC Cancer; 2007 Jul; 7():143. PubMed ID: 17663760
[TBL] [Abstract][Full Text] [Related]
12. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
[TBL] [Abstract][Full Text] [Related]
13. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
14. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
15. JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.
Hyakusoku H; Sano D; Takahashi H; Hatano T; Isono Y; Shimada S; Ito Y; Myers JN; Oridate N
J Exp Clin Cancer Res; 2016 Jan; 35():6. PubMed ID: 26754630
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
[TBL] [Abstract][Full Text] [Related]
17. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
Sesterhenn AM; Mandic R; Dünne AA; Werner JA
Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
[TBL] [Abstract][Full Text] [Related]
19. Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.
Preisler HD; Kotelnikov VM; LaFollette S; Taylor S; Mundle S; Wood N; Coon JS; Hutchinson J; Panje W; Caldarelli DD; Griem K
Clin Cancer Res; 1996 Sep; 2(9):1453-60. PubMed ID: 9816320
[TBL] [Abstract][Full Text] [Related]
20. p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck.
Gu X; Coates PJ; Boldrup L; Nylander K
Cancer Lett; 2008 May; 263(1):26-34. PubMed ID: 18194839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
